Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 20/20 | 0.85 |
| ▸ | ADORA1 | P30542 | 9/20 | 0.85 |
| ▸ | ADORA3 | P0DMS8 | 8/20 | 0.85 |
| ▸ | ADORA2A | P29274 | 12/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4051648 | 0.95 | ADORA2B (0.79) | ADORA2BADORA1ADORA3ADORA2A | |
| SCHEMBL4235347 | 0.95 | ADORA2B (0.79) | ADORA2BADORA1ADORA3ADORA2A | |
| SCHEMBL4051706 | 0.92 | ADORA2B (1.00) | ADORA2BADORA1ADORA3ADORA2A | |
| SCHEMBL4049629 | 0.92 | ADORA2B (1.00) | ADORA2BADORA1ADORA3ADORA2A | |
| SCHEMBL4054313 | 0.88 | ADORA2B (0.78) | ADORA2BADORA1ADORA3ADORA2A | |
| SCHEMBL4047846 | 0.88 | ADORA2B (0.91) | ADORA2BADORA1ADORA3ADORA2A | |
| SCHEMBL4065788 | 0.87 | ADORA2B (0.84) | ADORA2BADORA1ADORA3ADORA2A | |
| SCHEMBL4237457 | 0.87 | ADORA2B (0.89) | ADORA2BADORA1ADORA3ADORA2A | |
| SCHEMBL4058804 | 0.87 | ADORA2B (0.89) | ADORA2BADORA1ADORA3ADORA2A | |
| SCHEMBL4054164 | 0.85 | ADORA2B (0.78) | ADORA2BADORA1ADORA3ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261248-A1 | New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives | LABORATORIOS ALMIRALL, S.A. (ES) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261248-A1 | New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives | ADORA2B, ADORA2A, ADORA3 | ADORA2B 1/4885ADORA1 4/4885ADORA3 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.